Curb Opioid Misuse By Advancing Technology Act of 2016
Sponsored By: Representative Griffith, H. Morgan [R-VA-9]
Unknown
Summary
Curb Opioid Misuse By Advancing Technology Act of 2016 This bill amends the Federal Food, Drug, and Cosmetic Act to extend the marketing exclusivity period for certain brand name drugs that the Food and Drug Administration approves: (1) on the basis of new clinical abuse potential studies, and (2) with labeling that characterizes the drug's abuse-deterrent properties. This extension does not apply to the marketing exclusivity period for new chemical entities. The bill also extends the marketing exclusivity period for generics of these drugs.
Personalized for You
How does this bill affect your finances?
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Bill Overview
No Economic Impacts Identified for this Bill
Sponsors & CoSponsors
Sponsor
Griffith, H. Morgan [R-VA-9]
VA • R
Cosponsors
Rep. Connolly, Gerald E. [D-VA-11]
VA • D
Sponsored 4/29/2016
Rep. Bilirakis, Gus M. [R-FL-12]
FL • R
Sponsored 4/29/2016
Rep. Collins, Chris [R-NY-27]
NY • R
Sponsored 6/15/2016
Rep. Boyle, Brendan F. [D-PA-2]
PA • D
Sponsored 6/28/2016
Rep. Fitzpatrick, Michael G. [R-PA-8]
PA • R
Sponsored 7/7/2016
Rep. Veasey, Marc A. [D-TX-33]
TX • D
Sponsored 9/8/2016
Rep. Dold, Robert J. [R-IL-10]
IL • R
Sponsored 9/8/2016
Rep. Stewart, Chris [R-UT-2]
UT • R
Sponsored 9/19/2016
Rep. Wilson, Frederica S. [D-FL-24]
FL • D
Sponsored 11/14/2016
Sen. Blackburn, Marsha [R-TN]
TN • R
Sponsored 11/14/2016
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov